Can Serve Free LLC offers specialized investment advisory expertise to Clients who desire to understand oncology financial market dynamics and wisely build investment portfolios comprised of company stocks that fight Breast Cancer.
The Global Breast Cancer Market Size was valued at USD 31.9 Billion in 2022. The Market is growing at a compound annual growth rate (CAGR) of 10.3% from 2022 to 2032. The Worldwide Breast Cancer Market size is expected to reach USD 85.5 Billion by 2032.
While North America dominated the market with the largest revenue share of 38.61% in 2023, Europe is expected to grow the fastest during the forecast period.
Significant research efforts are focused on targeted therapies tailored to specific breast cancer types, particularly those characterized by overexpression of human epidermal growth factor receptor 2 (HER2).
Targeted drug therapy, including immunotherapy, directly addresses proteins in cancer cells, impeding their growth and proliferation. With HER2-targeted drugs demonstrating efficacy in inhibiting tumor progression, the market is witnessing a surge in the development and adoption of such therapies to meet the demand for combating breast cancer. In 2023, the hormone receptor segment was a significant contributor to the global market, accounting for the largest share at 66.97%.
The Breast Cancer Market segmentation, based on treatment, includes chemotherapy, surgery & radiation therapy, targeted therapy, biologic therapy, and hormone therapy.
For additional information on Breast Cancer, please review the video by MedBoard.